Heat shock protein 90α is a potential serological biomarker of acute rejection after renal transplantation

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Maehana, Takeshi ^a   Tanaka, Toshiaki ^a   Kitamura, Hiroshi ^a   Fukuzawa, Nobuyuki ^b   Ishida, Hideki ^c   Harada, Hiroshi ^b   Tanabe, Kazunari ^c   Masumori, Naoya ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO CITY GENERAL HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; HEAT SHOCK PROTEIN 90 ALPHA; IMMUNOGLOBULIN G; SEROLOGICAL BIOMARKER; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN 90;

ACUTE GRAFT REJECTION; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY MEDIATED REJECTION; AORTIC ENDOTHELIAL CELL; ARTICLE; BK VIRUS; CELL CULTURE; CHRONIC GRAFT REJECTION; COCULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NEPHROTOXICITY; NONHUMAN; PROTEIN BLOOD LEVEL; SKIN TRANSPLANTATION; ANIMAL; BLOOD; C57BL MOUSE; GRAFT REJECTION;

ANIMALS; BIOMARKERS; FEMALE; GRAFT REJECTION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY TRANSPLANTATION; MICE; MICE, INBRED C57BL;

EID: 84992327100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162942     Document Type: Article

References (19)

1. Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ. Targeting HSP90 for cancer therapy. Br J Cancer 2009; 100: 1523-1529. doi:10.1038/sj.bjc.6605066 PMID: 19401686.
2. Shukla HD, Pitha PM. Role of hsp90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis 2012; 2012:728605. doi:10.1155/2012/728605 Epub 2012 Oct 4. PMID: 23091704.
3. Dhillon VB, McCallum S, Norton P, Twomey BM, Erkeller-Yuksel F, Lydyard P, et al. Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 436-442. PMID: 8323395.
4. Tukaj S, Kleszczynski K, Vafia K, Groth S, Meyersburg D, Trzonkowski P, et al. Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid. Plos One 2013; 8: E70496. doi:10.1371/journal.pone.0070496 PMID: 23936217.
5. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, et al. Banff '09 meeting report: Antibody mediated graft deteriorationand implementation of Banff working groups. Am J Transplant 2010; 10: 464-471. doi:10.1111/j.1600-6143.2009.02987.x PMID: 20121738.
6. Mischitelli M, Bellizzi A, Anzivino E, Fioriti D, Boldorini R, Miglio U, et al. Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually available. Virol J 2008; 5:38. doi:10.1186/1743-422X-5-38 PMID: 18315864.
7. Birk OS, Gur SL, Elias D, Margalit R, Mor F, Carmi P, et al. The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci USA 1999; 96: 5159-5163. PMID: 10220435.
8. Abe T, Su CA, Iida S, Baldwin WM 3rd, Nonomura N, Takahara S, et al. Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allografts. Am J Transplant. 2014; 14: 1753- 1764. PMID: 25040187.
9. Kanda Y. Free statistical software: EZR (Easy R) on R commander. http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.html. Accessed 1 March 2012.
10. Whitesell L, Cook P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol 1996; 10: 705-712. PMID: 8776730.
11. Csermely P, Schnaider T, Soti C, Prohászka Z, Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998; 79: 129- 168. PMID: 9749880.
12. Buchner J. Hsp90 & Co.-A holding for folding. Trends Biochem Sci 1999; 24: 136-141. PMID: 10322418.
13. Saito K, Kukita K, Kutomi G, Okuya K, Asanuma H, Tabeya T, et al. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur J Immunol 2015; 45: 2028-2041. doi:10.1002/eji.201445293 PMID: 25871979.
14. Stephanou A, IsenbergDA, Akira S, Kishimoto T, Latchman DS. The nuclear factor interleukin-6 (NFIL6) and signal transducer and activator of transcription-3 (STAT -3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-6 but have opposite effects on its inducibility by heat shock. Biochem J 1998; 330: 189-195. PMID: 9461509.
15. Gwinner W. Renal transplant rejection markers. World J Urol 2007; 25: 445-455. PMID: 17786452.
16. Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010; 15: 35-41. doi:10.1097/MOT.0b013e3283342728 PMID: 19935064.
17. Soltaninejad E, Nicknam MH, Nafar M, Ahmadpoor P, Pourrezagholi F, Sharbafi MH, et al. Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection. Transpl Immunol 2015; 33: 1-6. doi:10.1016/j.trim.2015.05.002 PMID: 26002284.
18. Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, Haller H, et al. UrinarymiR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant 2011; 11: 2221- 2227. doi:10.1111/j.1600-6143.2011.03679.x PMID: 21812927.
19. Li W, Li Y, Guan S, Fan J, Cheng CF, Bright AM, et al. Extracellular heat shock protein-90α: linking hypoxia to skin cell motility and wound healing. EMBO J 2007; 26: 1221-1233. PMID: 17304217.